{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:18:05Z","timestamp":1793438285625,"version":"4.5.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"DOI":"10.1309\/ajcpg8lfjc0dhdqt","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T17:55:07Z","timestamp":1431539707000},"page":"901-904","source":"Crossref","is-referenced-by-count":32,"title":["Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations"],"prefix":"10.1093","volume":"143","author":[{"given":"Mark C.","family":"Mochel","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Piris","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA."},{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Nose","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA."},{"name":"Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA."},{"name":"Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"key":"key\n\t\t\t\t20180602035209_b1-1430901","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t20180602035209_b2-1430901","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesotheliomas, uveal and cutaneous melanoma, and MBAITs","volume":"30","author":"Carbone","year":"2012","journal-title":"J Transl Med"},{"key":"key\n\t\t\t\t20180602035209_b3-1430901","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Wadt","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"key\n\t\t\t\t20180602035209_b4-1430901","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180602035209_b5-1430901","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180602035209_b6-1430901","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"28","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180602035209_b7-1430901","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20180602035209_b8-1430901","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","article-title":"Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations","volume":"30","author":"Wiesner","year":"2012","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180602035209_b9-1430901","article-title":"Germline BAP1 mutations predispose also to multiple basal cell carcinomas [published online July 31, 2014]","author":"de la Fouchardiere","journal-title":"Clin Genet"},{"key":"key\n\t\t\t\t20180602035209_b10-1430901","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.humpath.2014.10.015","article-title":"BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations","volume":"46","author":"Piris","year":"2015","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20180602035209_b11-1430901","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180602035209_b12-1430901","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1999.tb09414.x","article-title":"BAP1, a candidate tumor suppressor protein that interacts with BRCA1","volume":"886","author":"Jensen","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20180602035209_b13-1430901","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t20180602035209_b14-1430901","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180602035209_b15-1430901","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMra0802968","article-title":"Inherited susceptibility to common cancers","volume":"359","author":"Foulkes","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602035209_b16-1430901","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t20180602035209_b17-1430901","first-page":"1018","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"43","author":"Pena-Llopis","year":"2011","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180602035209_b18-1430901","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/cup.12133","article-title":"Clumped perinuclear BAP1 expression is a frequent finding in sporadic epithelioid Spitz tumors","volume":"40","author":"Gammon","year":"2013","journal-title":"J Cutan Pathol"},{"key":"key\n\t\t\t\t20180602035209_b19-1430901","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","article-title":"New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment","volume":"18","author":"Ladanyi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180602035209_b20-1430901","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"key":"key\n\t\t\t\t20180602035209_b21-1430901","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1600-0463.2012.02909.x","article-title":"Somatic mutation of a tumor suppressor gene BAP1 is rare in breast, prostate, gastric, and colorectal cancers","volume":"120","author":"Je","year":"2012","journal-title":"APMIS"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/143\/6\/901\/24999637\/ajcpath143-0901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T01:54:47Z","timestamp":1566698087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/143\/6\/901\/1767387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,1]]},"published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpg8lfjc0dhdqt","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,6,1]]},"published":{"date-parts":[[2015,6,1]]}}}